Detection of cathepsin B, cathepsin L, cystatin C, urokinase plasminogen activator and urokinase plasminogen activator receptor in the sera of lung cancer patients
Open Access
- 11 May 2011
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 2 (4), 693-699
- https://doi.org/10.3892/ol.2011.302
Abstract
The present study aimed to determine the levels of cathepsin B (cath B), cathepsin L (cath L), cystatin C, urokinase plasminogen activator (u-PA) and urokinase plasminogen activator receptor (u-PAR) in the sera of patients with lung cancer compared to healthy controls using ELISA. Concomitantly, the relationship between the components and clinicopathological prognosis was analyzed. The study included 30 healthy volunteers and 105 lung cancer patients. Blood samples were collected and cath B, cath L, cystatin C, u-PA and u-PAR measurements were made using ELISA. Results showed that the levels of cath B, cath L, cystatin C, u-PA and u-PAR were significantly higher in the patient group compared to the healthy controls. The significance was marked for cath B and mild for u-PAR in correlation with lymph node metastasis. There was no significance for other parameters. Notably, patients with a combination of high cystatin C and high cath B levels had significantly lower survival probability as compared to those with cystatin C+/cath B− or with cystatin C−/cath B−. Similarly, patients with a combination of high u-PA and u-PAR experienced significantly shorter survival. Furthermore, the univariate analysis revealed that cath B, u-PAR, lymph node metastases, stage and grade were related to survival. However, findings of the multivariate Cox analysis indicated that the sera levels of cath B, u-PAR and lymph node metastases may serve as independent prognostic variables in patients with lung cancer.Keywords
This publication has 12 references indexed in Scilit:
- Prognostic significance of urokinase plasminogen activator receptor and its cleaved forms in blood from patients with non‐small cell lung cancerAPMIS, 2009
- Simultaneous expression of Cathepsins B and K in pulmonary adenocarcinomas and squamous cell carcinomas predicts poor recurrence-free and overall survivalLung Cancer, 2008
- Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinomaCancer, 2000
- Prognostic impact of Cathepsin B and matrix metalloproteinase-9 in pulmonary adenocarcinomas by immunohistochemical studyLung Cancer, 2000
- Cysteine Proteinases and Their Inhibitors in Extracellular Fluids: Markers for Diagnosis and Prognosis in CancerThe International Journal of Biological Markers, 2000
- Inhibition of B16 melanoma metastasis by overexpression of the cysteine proteinase inhibitor cystatin CMelanoma Research, 1999
- Lysosomal Proteases Cathepsins D, B, H, L and Their Inhibitors Stefins A and B in Head and Neck CancerBiological Chemistry Hoppe-Seyler, 1995
- Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancerCancer, 1994
- Cystatin C and cathepsin B in human colon carcinoma: Expression by cell lines and matrix degradationInternational Journal of Cancer, 1992
- Tumor-Associated Urokinase-Type Plasminogen Activator: Biological and Clinical SignificanceBiological Chemistry Hoppe-Seyler, 1992